% Expired Patents = 25.0

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 85

Loading Chart...

1 inventor (with patents filed for the assignee):

Gretchen M Unger (4 out of 7 patents)

4 patents: Sort by Forward Citations

1. 10987308 - Therapeutic nanoparticles and related compositions, methods and systems (2021-04-27),

2. 9650244 - Topical vaccination via DNA microparticles (2017-05-16),

3. 9132148 - Gene silencing by single-stranded polynucleotides (2015-09-15),

4. 6632671 - Nanoparticle encapsulation system and method (2003-10-14),

Company Overview

Genesegues, Inc. is a leading biotechnology company specializing in gene sequencing and analysis. With our cutting-edge technology and expertise, we provide innovative solutions for a wide range of industries including healthcare, agriculture, and environmental science. Our mission is to empower researchers and scientists with accurate and reliable genomic information to drive advancements and breakthroughs in their respective fields.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

4 Patents

#23 in Chaska, MN

#1,649 in Minnesota

#60,597 in US

Chaska, MN, United States of America

Genesegues, Inc.

Forward Citations = 85

1 inventor:

Gretchen M Unger (4 out of 7 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genesegues, Inc.. Retrieved from https://idiyas.com/company/genesegues

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]